Advertisement
Trends in Therapy
JAMA. 1978;240(21):2293-2295. doi: 10.1001/jama.1978.03290210075039

Therapy and Prophylaxis of Malaria

  1. Gordon M. Trenholme, MD;
  2. Paul E. Carson, MD
  1. From the Department of Pharmacology, Rush University, Chicago.

Abstract

Physicians should be prepared to provide prophylactic medications for travelers to malarious areas and to treat patients with malaria. Chloroquine hydrochloride is the suppressive agent of choice for treatment of mild infections due to all species of malaria except for those due to chloroquineresistant strains of Plasmodium falciparum. For treatment of severe infections with P falciparum and for treatment of all infections due to chloroquineresistant strains of P falciparum, quinine is the suppressive agent of choice. Chloroquine is also the prophylactic agent of choice for most travelers. To prevent infection with P vivax or P ovale, primaquine must also be given. A RBC glucose-6-phosphate dehydrogenase level should be obtained before administration of primaquine. For prophylaxis of chloroquine-resistant strains of P falciparum, no completely satisfactory regimen is presently available in the United States.

(JAMA 240:2293-2295, 1978)

Footnotes

  • Reprint requests to Section of Infectious Disease, Department of Medicine, Rush-Presbyterian St Lukes Medical Center, 1753 W Harrison, Chicago, IL 60612 (Dr Trenholme).

« Previous | Next Article »Table of Contents

More in JAMA & Archives Journals